Startseite

Cephalothin Sodium

Cephalothin Sodium

Spezifikationen

58-71-9CAS-Nummer
200-394-6EG-Nummer
sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylateIUPAC-Name
C16H15N2NaO6S2Chemische Formel
418.4 g/molMolekulargewicht
CEPHALOTHIN SODIUM; 58-71-9; cefalotin sodium; Cephalothin sodium salt; Sodium cephalothin; Seffin; Sodium cefalotin; Sodium cephalotin; Cefalotina sodica; Ceporacin; Cepovenin; Lospoven; Microtin; Synclotin; Toricelocin; Keflin In Plastic Container; C22G6EYP8B; 7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt; CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER; NSC-756667; CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER; CHEBI:3542; DTXSID30891362; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R-trans)-; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R,7R)-; SODIUM (6R,7R)-3-(ACETOXYMETHYL)-8-OXO-7-((2-THIENYLACETYL)AMINO)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE; Averon; sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cephalothin, Sodium; RefChem:54748; Cephalothin Monosodium Salt; Monosodium Salt, Cephalothin; Salt, Cephalothin Monosodium; DTXCID201030513; 200-394-6; Monosodium (6R,7R)-3-acetoxymethyl-8-oxo-7-(2-(thiophen-2-yl)acetylamino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate; Keflin; Cefalotin sodium salt; Cephalothin (sodium); Sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cefalothine; 7-(THIOPHENE-2-ACETAMIDO)CEPHALOSPORANIC ACID SODIUM; Cet Injektionsfl; MFCD00072025; Tokiosarl Ampullen; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodiumsalt, (6R,7R)-; Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester); Lovvalline Injektionsfl; MLS000069577; Lilly 38253; Cephalothin sodium [USAN]; Keflin N Injektionsflaschen; Cefalotina sodica [Spanish]; sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 7-(2-Thienylacetamido)cephalosporanic acid sodium salt; SMR000058777; EINECS 200-394-6; UNII-C22G6EYP8B; Cephalothin sodium [USAN:USP]; Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate acetate (ester); Prestwick_971; Keflin (TN); Cefalotin sodium CRS; sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; Cephalothin sodium (USP); Cefalotin sodium (JP18); CHEMBL1632; SCHEMBL148785; SPECTRUM1500166; CEFALOTIN SODIUM [JAN]; orb1224572; orb1309693; Cephalothin (sodium) (Standard); HMS500E19; HY-B1275R; CEFALOTIN SODIUM [MART.]; CEFALOTIN SODIUM [WHO-DD]; CEPHALOTHIN SODIUM [VANDF]; HMS1570O19; HMS1920K11; HMS2091A14; HMS2097O19; HMS3260J08; HMS3714O19; HY-B1275; Cephalothin sodium, Cefalotin sodium; Tox21_500283; CCG-38923; CEPHALOTHIN SODIUM SALT [MI]; MSK000940; s4594; AKOS015896088; CEFALOTIN SODIUM [EP IMPURITY]; AC19900; CEFALOTIN SODIUM [EP MONOGRAPH]; CS-4850; KS-1135; LP00283; NSC 756667; CEPHALOTHIN SODIUM [ORANGE BOOK]; CEPHALOTHIN SODIUM [USP IMPURITY]; NCGC00093737-01; NCGC00260968-01; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt; AC-15529; CEPHALOTHIN SODIUM [USP MONOGRAPH]; Cephalothin sodium salt, 96.0-101.0%; Cefalotin for impurity B identification CRS; EU-0100283; C 4520; C08100; D00907; EN300-268484; Q27106126; Cephalothin sodium salt, BioReagent, suitable for cell culture; Cefalotin sodium, European Pharmacopoeia (EP) Reference Standard; Cephalothin sodium, United States Pharmacopeia (USP) Reference Standard; sodium 7beta-(2-thienylacetamido)-3-acetoxymethyl-3-cephem-4-carboxylate; Cefalotin for impurity B identification, European Pharmacopoeia (EP) Reference Standard; sodium (6R, 7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate; sodium (6R,7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate; (6R)-3-[(acetyloxy)methyl]-8-oxo-7R-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, monosodium salt; (6R,7R)-3-ACETOXYMETHYL-8-OXO-7-(2-THIOPHEN-2-YL-ACETYLAMINO)-5-THIA-1-AZA-BICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE SODIUM; Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetateSynonyme